| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5590869 | Multiple Sclerosis and Related Disorders | 2017 | 16 Pages |
Abstract
DMT discontinuation in stable MS patients resulted in worsening of MS disease course for all patients, which improved upon DMT restart or switch. In contrast, 39% of MS stable patients experienced worsening of MS disease course when switched to another DMT, with DMT selection potentially impacting switch outcomes.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
Regina Berkovich,